Mijajlovic M, Aleksic V, Stojanovski N, Bornstein N
Neurol Sci. 2020; 41(12):3579-3587.
PMID: 33006058
DOI: 10.1007/s10072-020-04748-0.
Proudfoot D
Cold Spring Harb Perspect Biol. 2019; 11(10).
PMID: 31138543
PMC: 6771368.
DOI: 10.1101/cshperspect.a035303.
Kleiber Balderrama C, Rosenthal A, Lans D, Singh J, Bartels C
Arthritis Care Res (Hoboken). 2016; 69(9):1400-1406.
PMID: 27898996
PMC: 5472491.
DOI: 10.1002/acr.23160.
Mitton-Fitzgerald E, Gohr C, Bettendorf B, Rosenthal A
Curr Rheumatol Rep. 2016; 18(5):25.
PMID: 27032788
PMC: 5453179.
DOI: 10.1007/s11926-016-0574-z.
Abhishek A, Doherty M
Nat Rev Rheumatol. 2010; 7(2):96-104.
PMID: 21102543
DOI: 10.1038/nrrheum.2010.182.
Purine receptors modulate chondrocyte extracellular inorganic pyrophosphate production.
Rosenthal A, Hempel D, Kurup I, Masuda I, Ryan L
Osteoarthritis Cartilage. 2010; 18(11):1496-501.
PMID: 20709180
PMC: 2975862.
DOI: 10.1016/j.joca.2010.08.004.
Dexamethasone promotes calcium pyrophosphate dihydrate crystal formation by articular chondrocytes.
Fahey M, Mitton E, Muth E, Rosenthal A
J Rheumatol. 2009; 36(1):163-9.
PMID: 19132782
PMC: 2640436.
DOI: 10.3899/jrheum.080528.
The ank gene story.
Ryan L
Arthritis Res. 2001; 3(2):77-9.
PMID: 11178113
PMC: 128882.
DOI: 10.1186/ar143.
Association between synovial fluid levels of inorganic pyrophosphate and short term radiographic outcome of knee osteoarthritis.
Doherty M, Belcher C, Regan M, Jones A, Ledingham J
Ann Rheum Dis. 1996; 55(7):432-6.
PMID: 8774160
PMC: 1010205.
DOI: 10.1136/ard.55.7.432.
Retinoic acid stimulates pyrophosphate elaboration by cartilage and chondrocytes.
Rosenthal A, Henry L
Calcif Tissue Int. 1996; 59(2):128-33.
PMID: 8687982
DOI: 10.1007/s002239900099.
Understanding inorganic pyrophosphate metabolism: toward prevention of calcium pyrophosphate dihydrate crystal deposition.
Ryan L, McCarty D
Ann Rheum Dis. 1995; 54(12):939-41.
PMID: 8546522
PMC: 1010054.
DOI: 10.1136/ard.54.12.939.
Proceedings of a symposium on crystal-related arthropathies. 22 October and 23 October, 1982, Bristol Polytechnic, Bristol.
Ann Rheum Dis. 1983; 42 Suppl 1:1-114.
PMID: 6615023
PMC: 1035029.
DOI: 10.1136/ard.42.suppl_1.1-a.
Crystals, joints, and consternation.
McCarty D
Ann Rheum Dis. 1983; 42(3):243-53.
PMID: 6344808
PMC: 1001123.
DOI: 10.1136/ard.42.3.243.
Pathogenesis of chondrocalcinosis and pseudogout. Metabolism of inorganic pyrophosphate and production of calcium pyrophosphate dihydrate crystals.
Caswell A, Hearn P, McGuire M, Russell R
Ann Rheum Dis. 1983; 42 Suppl 1:27-37.
PMID: 6311118
PMC: 1035036.
DOI: 10.1136/ard.42.suppl_1.27.
Pyrophosphohydrolase activity and inorganic pyrophosphate content of cultured human skin fibroblasts. Elevated levels in some patients with calcium pyrophosphate dihydrate deposition disease.
Ryan L, Wortmann R, Karas B, Lynch M, McCarty D
J Clin Invest. 1986; 77(5):1689-93.
PMID: 3009553
PMC: 424575.
DOI: 10.1172/JCI112487.
Interaction of polymorphonuclear leukocytes with calcium pyrophosphate dihydrate crystals deposited in chondrocalcinosis cartilage.
Ishikawa H, Ueba Y, Isobe T, Hirohata K
Rheumatol Int. 1987; 7(5):217-21.
PMID: 2827293
DOI: 10.1007/BF00541380.
Synovial fluid pyrophosphate and nucleoside triphosphate pyrophosphatase: comparison between normal and diseased and between inflamed and non-inflamed joints.
Pattrick M, Hamilton E, Hornby J, Doherty M
Ann Rheum Dis. 1991; 50(4):214-8.
PMID: 1851409
PMC: 1004389.
DOI: 10.1136/ard.50.4.214.
Deposition of calcium pyrophosphate dihydrate crystals in a soft tissue chondroma.
Athanasou N, Caughey M, Burge P, Woods C
Ann Rheum Dis. 1991; 50(12):950-2.
PMID: 1768168
PMC: 1004590.
DOI: 10.1136/ard.50.12.950.
